Literature DB >> 33316294

Hyperglycemia induces RAGE-dependent hippocampal spatial memory impairments.

Zeinab Momeni1, Joseph Neapetung1, Anthony Pacholko1, Tabitha Achan Bol Kiir2, Yasuhiko Yamamoto3, Lane K Bekar1, Verónica A Campanucci4.   

Abstract

Diabetes is a prevalent metabolic disorder that has long been associated with changes in different regions of the brain, including the hippocampus. Changes in hippocampal synaptic plasticity and subsequent impairment in cognitive functions such as learning and memory, are well documented in animal models of type 1 and type 2 diabetes. It is known that RAGE contributes to peripheral micro- and macro-vascular complications of diabetes. However, it is still unknown if RAGE plays a similar role in the development of CNS complications of diabetes. Therefore, we hypothesize that RAGE contributes to cognitive dysfunction, such as learning and memory impairments, in a mouse model of STZ-induced hyperglycemia. Control and STZ-induced hyperglycemic mice from WT and RAGE-KO groups were used for the behavioral experiments. While STZ-induced hyperglycemia decreased locomotor activity in the open field (OF) test, it did not affect the recognition memory in the novel object recognition (NOR) test in either genotype. Spatial memory, however, was impaired in STZ-induced hyperglycemic mice in WT but not in RAGE-KO group in both the Barnes maze (BM) and the Morris water maze (MWM) tests. Consistently, the RAGE antagonist FPS-ZM1 protected WT STZ-induced hyperglycemic mice from spatial memory impairment in the BM test. Our findings indicate that the parameters associated with locomotor activity and recognition memory were independent of RAGE in STZ-induced hyperglycemic mice. In contrast, the parameters associated with hippocampal-dependent spatial memory were dependent on RAGE expression.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Cognitive dysfunction; Locomotor activity; Metabolic disorder; Mouse model of STZ-induced hyperglycemia; Receptor for advanced glycation end products

Mesh:

Year:  2020        PMID: 33316294     DOI: 10.1016/j.physbeh.2020.113287

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  5 in total

Review 1.  Cognitive Deficits in Type-1 Diabetes: Aspects of Glucose, Cerebrovascular and Amyloid Involvement.

Authors:  Justin Pickering; Rachel Wong; Hani Al-Salami; Virginie Lam; Ryu Takechi
Journal:  Pharm Res       Date:  2021-09-03       Impact factor: 4.200

Review 2.  Evolution of the Human Diet and Its Impact on Gut Microbiota, Immune Responses, and Brain Health.

Authors:  Brigitte M González Olmo; Michael J Butler; Ruth M Barrientos
Journal:  Nutrients       Date:  2021-01-10       Impact factor: 5.717

3.  Receptor for advanced glycation end products aggravates cognitive deficits in type 2 diabetes through binding of C-terminal AAs 2-5 to mitogen-activated protein kinase kinase 3 (MKK3) and facilitation of MEKK3-MKK3-p38 module assembly.

Authors:  Xiao-Yan Zhou; Chang-Jiang Ying; Bin Hu; Yu-Sheng Zhang; Tian Gan; Yan-Dong Zhu; Nan Wang; An-An Li; Yuan-Jian Song
Journal:  Aging Cell       Date:  2022-01-26       Impact factor: 9.304

Review 4.  Pathophysiology of RAGE in inflammatory diseases.

Authors:  Hanbing Dong; Yue Zhang; Yu Huang; Hui Deng
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

5.  The molecular mechanism underlying mitophagy-mediated hippocampal neuron apoptosis in diabetes-related depression.

Authors:  Jian Liu; Lin Liu; Yuan-Shan Han; Jian Yi; Chun Guo; Hong-Qing Zhao; Jia Ling; Yu-Hong Wang
Journal:  J Cell Mol Med       Date:  2021-07-02       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.